Inhibition of rotavirus infection in vitro and in vivo by a synthetic peptide from VP4

By Ijaz M.K.   Nur-E-Kamal M.S.A.   Dar F.K.   Uduman S.   Redmond M.J.   Attah-Poku S.K.   Dent D.   Babiuk L.A.  

Vaccine, Vol. 16, Iss. 9, 1998-05 ,pp. : 916-920

Elsevier

Access to resources Recommend Favorite

Nasal immunisation with Salmonella typhimurium producing rotavirus VP2 and VP6 antigens stimulates specific antibody response in serum and milk but fails to protect offspring

By Coste A.   Cohen J.   Reinhardt M.   Kraehenbuhl J.-P.   Sirard J.-C.  

Vaccine, Vol. 19, Iss. 30, 2001-07 ,pp. : 4167-4174

Elsevier

Access to resources Recommend Favorite

Bacterial expression of the major antigenic regions of porcine rotavirus VP7 induces a neutralizing immune response in mice

By Wang L.   Huang J.-a.   Nagesha H.S.   Smith S.C.   Phelps A.   Holmes I.   Martyn J.C.   Coloe P.J.   Reeves P.R.  

Vaccine, Vol. 17, Iss. 20, 1999-06 ,pp. : 2636-2645

Elsevier

Access to resources Recommend Favorite

Rotavirus VP7 epitope mapping using fragments of VP7 displayed on phages

By Huang J.-a.   Wang L.   Firth S.   Phelps A.   Reeves P.   Holmes I.  

Vaccine, Vol. 18, Iss. 21, 2000-04 ,pp. : 2257-2265

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of live attenuated human-bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3 or 4 in adults, children and infants

By Clements-Mann M.L.   Makhene M.K.   Mrukowicz J.   Wright P.F.   Hoshino Y.   Midthun K.   Sperber E.   Karron R.   Kapikian A.Z.  

Vaccine, Vol. 17, Iss. 20, 1999-06 ,pp. : 2715-2725

Elsevier

Access to resources Recommend Favorite